Finance

Results: 1009-1020 of 33702

KBRA Assigns Preliminary Ratings to Temple Quay No.2 PLC

PR Newswire associated0

Mesh Suture, Inc. Secures Key Regulatory Approvals, Accelerating Global Access to DURAMESH™ for Surgeons Worldwide

Researchers at Chemify’s first Chemifarm—a fully automated chemistry facility regarded as the world’s most advanced laboratory for molecular design and synthesis, which opened in Glasgow, Scotland in June of 2025. Chemify, the deep-tech pioneer fusing chemistry, robotics, computation, and Chemputation—Chemify’s purpose-built AI to digitize molecule creation—announced today it has raised over $50 million in Series B funding to help accelerate its mission of becoming the global leader in digital chemistry, molecular design and manufacturing. Co-led by Wing Venture Capital and Insight Partners, the financing will scale Chemify’s Chemputation platform and Chemifarm facilities, transforming how molecules are designed and made for medicines and advanced materials.

Chemify Raises More Than $50 Million in Oversubscribed Series B to Drive Global Expansion of Digital Chemistry and Discovery

PR Newswire associated0

Ajinomoto Bio-Pharma Services and Gene Tools Announce Collaboration to Expand Access to PMO Therapeutics

Enedym Inc. Secures Investment from Honda Motor Co., Ltd.

Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital

Carevance platform expands access to GE HealthCare’s clinical excellence with advanced patient monitoring and new perioperative hypotension management capability

MacuMira and Keeler announce strategic partnership to expand Dry AMD therapy

Bojoko Reports Best Year on Record After Just Three Quarters

Change in the Sobi Board of Directors

Major NHS AI trial delivers unprecedented time and cost savings

New blueprint for AI regulation could speed up planning approvals, slash NHS waiting times, and drive growth and public trust